• Hub71+ Life Sciences offers startups in BioTech, MedTech, and digital health direct access to Abu Dhabi’s health ecosystem.
• Founders gain support for early clinical validation, regulatory guidance, funding, and market access to scale innovations globally.
• Abu Dhabi strengthens its role as a regional hub for healthcare innovation, precision medicine, and data-driven solutions.

Hub71

Hub71, Abu Dhabi’s global tech ecosystem, launched Hub71+ Life Sciences to accelerate healthcare innovation. The new platform targets BioTech, MedTech, and digital health startups. 

Founders joining the ecosystem get direct access to hospitals, investors, regulators, and industry partners across Abu Dhabi. The initiative supports translating lab research into market-ready solutions faster.

“ With Hub71+ Life Sciences, we are channeling that experience into a dedicated environment where founders, researchers, market players, and investors can collaborate to advance healthcare innovation. The initiative targets startups developing breakthrough solutions in HealthTech, BioTech, and life sciences, strengthening Abu Dhabi’s role in driving global healthcare innovation,” said Ahmad Ali Alwan, CEO of Hub71. 

HealthTech

The initiative aligns with the Department of Health – Abu Dhabi (DoH), Emirates Drug Establishment (EDE), and the HELM cluster. All of which are founding partners of the new platform. Furthermore, they are all committed to  creating a high-functioning life sciences economy anchored in Abu Dhabi.  Additionally, all of them reinforce Abu Dhabi’s focus on precision medicine, biomanufacturing, and data-driven care.

The Abu Dhabi Early Childhood Authority (ECA), Cleveland Clinic Abu Dhabi and Ultrahuman will reinforce the platform as anchor partners. Additionally, a total of 12 partners will collaborate with startups to explore investment opportunities and accelerate the introduction of transformative innovations to market.

 “As a Founding Partner, EDE will work side-by-side with innovators to engage early with regulators, clarify evidence expectations and make use of collaborative pathways so safe, effective solutions reach patients faster,” said Dr. Shaikha Al Mazrouei, Director of Reference National Laboratory, Drug Department, Emirates Drug Establishment (EDE).

The launch builds on momentum from local life sciences startups like BioSapien, Ovasave, and Biotwin, which are already advancing oncology, fertility, and AI-driven medicine.

Hub71+ Life Sciences seeks to create shared value by linking investors, corporates, and startups. This ecosystem aims to accelerate innovation while boosting Abu Dhabi’s competitiveness in the regional life sciences market.